BIRC5 and osteosarcoma: Similarly, the sensitivity to cisplatin was increased by celecoxib in a human osteosarcoma cell line (MG-63) and this effect was linked to a down-regulation of anti-apoptotic proteins survivin, Bcl-2, and an inhibition of the survival pathway PI3K/Akt [112].